ESCRS - Expectations need to be managed in combined cataract-AMD patients ;
ESCRS - Expectations need to be managed in combined cataract-AMD patients ;

Expectations need to be managed in combined cataract-AMD patients

Expectations need to be managed in combined cataract-AMD patients
Dermot McGrath
Dermot McGrath
Published: Monday, September 26, 2016
congress-news_olsen_2166Age-related macular degeneration (AMD) and cataracts both progress with age, with the current body of evidence indicating that cataract surgery is not likely to cause AMD progression, Timothy W Olsen MD told delegates attending yesterday’s ESCRS Clinical Research Symposium on Cataract and Macular Disease in Copenhagen. “The key to this is carefully managing patients’ expectations and to be honest with them about what to expect in the course of managing these two age-related conditions. We cannot prevent the ageing process but I think the key concept to keep in mind relates to optimising ageing,” said Dr Olsen, Emory University, Atlanta, USA. Epidemiological studies clearly show the extent of the task facing eye care physicians in the near future, said Dr Olsen. “The projections for advanced AMD in the US alone are an incidence of 125,000 patients per year treated, and 25,000 new cases every year by 2020. For cataracts, about 50% of the population will have visually significant cataract by age 75,” he said. While early population-based studies suggested a possible increased risk of progression to AMD as a result of cataract surgery, Dr Olsen said that this view has since been reappraised. “We need to understand the era in which these studies were conducted. Many of the participants were aphakic and the advanced AMD was actually geographic atrophy. So while alarm bells were ringing, we were all able to breathe a little easier when the AREDS study was published showing no clear effect of cataract extraction on AMD progression. Macular degeneration is going to progress anyway and there may not be as tight a relationship as the population-based studies had shown,” he said.
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;